VI BYPASS SYRINGE Trademark

Trademark Overview

On Friday, December 4, 2020, a trademark application was filed for VI BYPASS SYRINGE with the United States Patent and Trademark Office. The USPTO has given the VI BYPASS SYRINGE trademark a serial number of 90358371. The federal status of this trademark filing is REGISTERED as of Tuesday, July 4, 2023. This trademark is owned by Vascular Integrity. The VI BYPASS SYRINGE trademark is filed in the Medical Instrument Products category with the following description:

Medical syringes; medical apparatus, namely, blood culture collection systems involving containing medical syringes; and medical appararus, namely, drug delivery systems involving containing medical syringes
vi bypass syringe

General Information

Serial Number90358371
Word MarkVI BYPASS SYRINGE
Filing DateFriday, December 4, 2020
Status700 - REGISTERED
Status DateTuesday, July 4, 2023
Registration Number7101361
Registration DateTuesday, July 4, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 7, 2021

Trademark Statements

Goods and ServicesMedical syringes; medical apparatus, namely, blood culture collection systems involving containing medical syringes; and medical appararus, namely, drug delivery systems involving containing medical syringes
Disclaimer with Predetermined Text"BYPASS SYRINGE"

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, February 9, 2021
Primary Code010
First Use Anywhere DateTuesday, January 3, 2023
First Use In Commerce DateTuesday, January 3, 2023

Trademark Owner History

Party NameVascular Integrity
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressIrvine, CA 92606
Party NameVascular Integrity
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressIrvine, CA 92606
Party NameVascular Integrity
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressIrvine, CA 92606

Trademark Events

Event DateEvent Description
Tuesday, July 4, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, July 4, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, May 30, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, May 29, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, May 23, 2023STATEMENT OF USE PROCESSING COMPLETE
Tuesday, May 2, 2023USE AMENDMENT FILED
Tuesday, May 23, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 2, 2023TEAS STATEMENT OF USE RECEIVED
Thursday, November 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 1, 2022SOU EXTENSION 2 GRANTED
Tuesday, November 1, 2022SOU EXTENSION 2 FILED
Tuesday, November 1, 2022TEAS EXTENSION RECEIVED
Tuesday, May 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, April 30, 2022SOU EXTENSION 1 GRANTED
Saturday, April 30, 2022SOU EXTENSION 1 FILED
Saturday, April 30, 2022TEAS EXTENSION RECEIVED
Tuesday, November 2, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 7, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 7, 2021PUBLISHED FOR OPPOSITION
Wednesday, August 18, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, August 2, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 2, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 1, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 1, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, May 30, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, May 30, 2021NON-FINAL ACTION E-MAILED
Sunday, May 30, 2021NON-FINAL ACTION WRITTEN
Monday, May 24, 2021ASSIGNED TO EXAMINER
Tuesday, February 9, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 8, 2020NEW APPLICATION ENTERED

Related Keywords

syringe bypass medical syringes systems containing involving namely drug delivery appararus collection